(Q46702416)

24 December 2017

title

The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype (English)

1 reference

24 December 2017

0 references

M E A Borm

1

1 reference

24 December 2017

A A van Bodegraven

2

1 reference

24 December 2017

C J J Mulder

3

1 reference

24 December 2017

G Kraal

4

1 reference

24 December 2017

G Bouma

5

1 reference

24 December 2017

publication date

13 March 2008

1 reference

24 December 2017

published in

Genes and Immunity

1 reference

24 December 2017

volume

9

1 reference

24 December 2017

page(s)

274-278

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/gene.2008.9

exact match

0 references

cites work

Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

NOD-LRR proteins: role in host-microbial interactions and inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

The immunological and genetic basis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Crohn's disease and the NOD2 gene: a role for paneth cells

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.9

7 January 2021

Identifiers

DOI

10.1038/GENE.2008.9

1 reference

24 December 2017

PubMed ID

18340358

1 reference

24 December 2017